Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Montical-XT is a branded generic combination medication marketed by ESS Remedies, primarily utilized within the orthopedic therapeutic category. It is formulated to address bone health and nutritional deficiencies, typically containing calcium carbonate (a calcium supplement), cholecalciferol (Vitamin D3), and a complex of active B-vitamins including mecobalamin (Vitamin B12), levomefolic acid (the active form of folate), and pyridoxal phosphate (the active form of Vitamin B6). This combination supports bone mineralization by providing elemental calcium and enhancing its absorption via Vitamin D receptor activation, while the B-vitamin components support nerve health and homocysteine metabolism. It is commonly prescribed for the management of osteoporosis, osteomalacia, and other conditions associated with calcium and vitamin D deficiency.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on calcium carbonate + cholecalciferol + mecobalamin + levomefolic acid + pyridoxal phosphate.